Neogen Chemicals Limited
All news and filings related to Neogen Chemicals Limited.
View all news & filings- Medium impact
Neogen Chemicals Approves Qualified Institutions Placement (QIP) with Floor Price of ₹2,189.73
Neogen Chemicals Limited's Fund-Raising Committee approved a Qualified Institutions Placement (QIP) of equity shares. The floor price is set at ₹2,189.73 per share. The QIP issue opened on September 10, 2026, following earlier approvals from the Board and shareholders.
Read the summary - Medium impact
Neogen Chemicals Sets Floor Price at ₹2,189.73 for QIP
Neogen Chemicals' Fund-Raising Committee approved a Qualified Institutions Placement (QIP) with a floor price of ₹2,189.73 per equity share. The decision follows board and shareholder approvals. The issue price will be determined with lead managers, and the preliminary placement document will be filed on September 10, 2026.
Read the summary - Medium impact
Neogen Chemicals Receives Show Cause Notice for ₹6.97 Crore Tax Demand
Neogen Chemicals received a show cause notice for ₹6.97 crore tax demand, interest, and penalty for FY 2022-23. The notice cites GSTR mismatches and excess ITC claims. The company is evaluating and will file a reply, expecting no material impact beyond the stated amount.
Read the summary - Medium impact
Neogen Chemicals Receives ₹6.97 Crore Tax Demand Notice
Neogen Chemicals received a show cause cum demand notice for ₹6.97 crore for FY23. The notice includes tax, interest, and penalty, stemming from GSTR-1 vs. GSTR-3B mismatches and excess ITC claims. The company is evaluating the notice and will file a reply, stating no material impact on its operations.
Read the summary - Medium impact
Neogen Ionics to acquire undertaking from Neogen Chemicals for ₹245 Crore
Neogen Chemicals Limited's subsidiary, Neogen Ionics, will acquire an undertaking from Neogen Morita New Materials for ₹245 Crore. The transaction, aimed at consolidating electrolyte salt businesses, is expected to be completed by March 31, 2027. The net worth of the transferred undertaking was ₹155.52 Crore as of March 31, 2026.
Read the summary - Low impact
Neogen Chemicals: Relative of Promoter Gifts 354 Shares to Brother
Mrs. Heena Hitesh Reshamwala gifted 354 equity shares of Neogen Chemicals to her brother-in-law, Mr. Viren Reshamwala, on August 25, 2026. This off-market transaction represents a small fraction of the company's paid-up capital. The disclosures were made under SEBI's insider trading regulations.
Read the summary - Medium impact
Neogen Chemicals Ltd. 37th AGM Concludes: All Resolutions Approved, Final Dividend Declared
Neogen Chemicals Limited's 37th AGM on August 21, 2026, saw all resolutions approved. Key approvals included the FY26 financial statements, a final dividend of ₹1 per share, director re-appointment, securities issuance authorization, and cost auditor remuneration ratification.
Read the summary - Medium impact
Neogen Chemicals Ltd Holds 37th AGM, Approves Financials and ₹1 Dividend
Neogen Chemicals Limited held its 37th AGM on August 21, 2026. Shareholders approved the FY26 audited standalone and consolidated financial statements. A final dividend of ₹1 per share was declared. Dr. Harin Kanani was re-appointed as Managing Director. All resolutions passed with requisite majority.
Read the summary - Low impact
Neogen Chemicals Limited Holds 37th AGM on Aug 21, 2026
Neogen Chemicals Limited held its 37th AGM on August 21, 2026, conducted via VC/OAVM. Key agenda items included adopting FY26 financial statements, proposing a ₹1 dividend per share, and authorizing securities issuance. Shareholders raised questions on growth, new products, and financial matters.
Read the summary - High impact
Neogen Chemicals Q1 FY27 Revenue Surges 34% to ₹250 Crore; PAT Jumps 67%
Neogen Chemicals reported Q1 FY27 consolidated revenue of ₹250 crore (up 34% YoY) and PAT of ₹17 crore (up 67% YoY). EBITDA margin improved to 19.3%. The company revised its FY27 revenue guidance upwards to ₹950-1,050 crore. A ₹600 crore QIP is approved to reduce debt and fund growth. Battery chemical revenue is projected at ₹300 crore for FY27.
Read the summary - Low impact
Neogen Chemicals Announces 37th AGM on Aug 21, 2026, via Video Conference
Neogen Chemicals Limited will hold its 37th Annual General Meeting (AGM) on August 21, 2026, at 5:00 PM IST via video conference. Shareholders can participate and e-vote. Book closure is from August 14 to August 21, 2026. Annual reports are available online.
Read the summary - Low impact
Neogen Chemicals sets Aug 13, 2026 as Record Date for Dividend; Book Closure Aug 14-21
Neogen Chemicals Limited has set August 13, 2026, as the record date for its final dividend for FY26. The book closure for determining eligible shareholders will be from August 14 to August 21, 2026. The dividend is subject to approval at the 37th Annual General Meeting.
Read the summary - Medium impact
Neogen Chemicals Announces 37th AGM on Aug 21, 2026, to Consider FY26 Results & Dividend
Neogen Chemicals will hold its 37th AGM on August 21, 2026, to approve FY26 results and a ₹1 dividend. The company plans to raise up to ₹600 crore via QIP. Key dates include August 13 for record date and August 18-20 for e-voting.
Read the summary - Low impact
Neogen Chemicals: Audio Recording of Analyst Call Available on Website
Neogen Chemicals Limited has made the audio recording of its Analyst/Investor Conference Call, held on July 27, 2026, available on its website. The recording can be accessed via a provided link.
Read the summary - Low impact
Neogen Chemicals Releases Analyst Call Recording; Available on Website
Neogen Chemicals has released the audio recording of its Analysts/Investors Conference Call held on July 27, 2026. The recording is available on the company's website for stakeholders to access.
Read the summary - High impact
Neogen Chemicals Q1 FY27 Revenue Jumps 34% to ₹250 Crore, PAT Surges 67%
Neogen Chemicals reported a 34% YoY revenue growth to ₹250.3 crore and a 67% PAT surge to ₹17.1 crore for Q1 FY27. Consolidated EBITDA increased by 53% to ₹48.2 crore. The company's board approved raising ₹600 crore via QIP for expansion. Battery materials projects are on track.
Read the summary - High impact
Neogen Chemicals Q1 FY27 Revenue Up 34% to ₹250 Crore, PAT Rises 67% to ₹17.1 Crore
Neogen Chemicals reported Q1 FY27 consolidated revenue of ₹250.3 crore, up 34% YoY. PAT increased 67% to ₹17.1 crore. The company received board approval to raise up to ₹600 crore via QIP. Dahej plant reconstruction is complete, and battery materials projects are on track.
Read the summary - High impact
Neogen Q1 FY27 Revenue up 34% to ₹250 Crore, PAT soars 67% to ₹17 Crore
Neogen Chemicals reported Q1 FY27 consolidated revenue of ₹250 crore, up 34% YoY. PAT increased by 67% YoY to ₹17 crore. The company approved raising up to ₹600 crore via QIP. Reconstruction of the Dahej plant is complete. Battery materials projects with ₹1,795 crore CAPEX are on track.
Read the summary - Low impact
Neogen Chemicals: No Deviation in Utilization of ₹161 Crore Preferential Issue Funds
Neogen Chemicals Limited confirms no deviation in the utilization of ₹161 crore raised via preferential issue. Funds were allocated to subsidiary investment (₹100 crore), working capital (₹21 crore), and general corporate purposes (₹40 crore). All funds were utilized as planned, as per the Monitoring Agency Report by CRISIL Ratings.
Read the summary - Low impact
Neogen Chemicals: No Deviation in Preferential Issue Fund Utilization for Q1 FY27
Neogen Chemicals reports no deviation in the utilization of ₹161 crore raised via preferential issue for the quarter ended June 30, 2026. Funds were allocated to subsidiaries (₹100 crore), working capital (₹21 crore), and general corporate purposes (₹40 crore). CRISIL Ratings confirmed full utilization.
Read the summary - Low impact
Neogen Chemicals: Zero Deviation in Preferential Issue Fund Utilization for Q1FY27
Neogen Chemicals reports zero deviation in the utilization of ₹161 crore raised via Preferential Issue for the quarter ended June 30, 2026. Funds were allocated to subsidiaries, working capital, and general corporate purposes, as confirmed by CRISIL Ratings Limited, the Monitoring Agency. The company has fully utilized the issue proceeds.
Read the summary - Low impact
Neogen Chemicals: No Deviation in Preferential Issue Fund Utilization for Q1FY27
Neogen Chemicals confirms no deviation in the utilization of ₹161 crore raised via preferential issue for the quarter ended June 30, 2026. Funds were allocated to subsidiaries, working capital, and general corporate purposes. CRISIL Ratings report also confirms no variation.
Read the summary - Medium impact
Neogen Chemicals Board Approves Q1 FY26 Results, Plans ₹600 Crore Fundraising
Neogen Chemicals reported Q1 FY26 results with standalone profit after tax at ₹19.44 crore and consolidated profit after tax at ₹17.11 crore. The Board approved raising funds up to ₹600 crore, potentially via QIP. The 37th AGM is scheduled for August 21, 2026.
Read the summary - Medium impact
Neogen Chemicals Board Approves Q1 FY27 Results, Proposes Dividend, Plans Fundraising
Neogen Chemicals reported its Q1 FY27 results. The Board approved the financial results and declared a record date of August 13, 2026, for a final dividend for FY26. The company also received in-principle approval to raise up to ₹600 crore and appointed CNK & Associates as internal auditors.
Read the summary - High impact
Neogen Chemicals Approves Q1 FY26 Results, Plans Fundraise Up to ₹600 Crore, Sets AGM for Aug 21
Neogen Chemicals reported its Q1 FY26 results, with Board approval for financial results and the annual report. The 37th AGM is scheduled for August 21, 2026. The company also received in-principle approval to raise up to ₹600 crore and appointed CNK & Associates as Internal Auditor.
Read the summary - Medium impact
Neogen Chemicals Board Approves Q1 FY26 Results, Plans Fundraise & AGM
Neogen Chemicals approved Q1 FY26 results, with standalone profit at ₹19.44 crore and consolidated profit at ₹17.11 crore. The company plans to raise up to ₹600 crore. The 37th AGM is scheduled for August 21, 2026, with a record date of August 13, 2026.
Read the summary - High impact
Neogen Chemicals Board Approves Q1 FY26 Results, Plans Fundraise Up To ₹600 Cr
Neogen Chemicals reported its Q1 FY26 results, with standalone profit at ₹19.44 crore and consolidated profit at ₹17.11 crore. The board approved convening the 37th AGM on August 21, 2026, and set August 13, 2026, as the record date for dividend. Additionally, the company received in-principle approval to raise up to ₹600 crore.
Read the summary - High impact
Neogen Chemicals Board Approves Q1 FY27 Results, Plans ₹600 Cr Fundraising
Neogen Chemicals reported Q1 FY27 results with standalone PAT at ₹19.44 crore and consolidated PAT at ₹17.11 crore. The Board approved the Q1 FY27 financial results and an in-principle approval to raise up to ₹600 crore. The 37th AGM is scheduled for August 21, 2026, with a record date of August 13, 2026, for dividend.
Read the summary - Low impact
Neogen Chemicals Publishes Newspaper Ad for Share Transfer to IEPF Authority
Neogen Chemicals Limited published a notice on July 23, 2026, regarding the transfer of equity shares to the IEPF Authority. This action is in compliance with SEBI regulations for unclaimed dividends. Shareholders who have not claimed dividends for seven consecutive years are subject to this transfer. Information is available on the company website.
Read the summary - Low impact
Neogen Chemicals Schedules Q1 FY27 Earnings Conference Call for July 27
Neogen Chemicals Limited will host an Earnings Conference Call on July 27, 2026, at 4:00 PM IST to discuss its Q1 FY27 results. Senior management will present and address investor queries.
Read the summary - High impact
Neogen Chemicals Rating Downgraded by CRISIL to A-/Negative; A2+ Short Term
CRISIL has downgraded Neogen Chemicals Limited's long-term rating to A-/Negative and short-term rating to A2+. This is due to delays in the battery chemicals project and insurance claims. Neogen Ionics Limited's long-term rating is now BBB+/Negative. The total rated bank facilities for Neogen Chemicals stand at ₹680 Crore.
Read the summary - High impact
Neogen Chemicals' Credit Rating Downgraded by CRISIL to A-/Negative
CRISIL has downgraded Neogen Chemicals' credit rating to A-/Negative from A/Negative and its short-term rating to A2+ from A1. Neogen Ionics Limited's rating was also downgraded to BBB+/Negative from A-/Negative. The downgrades are attributed to delays in the battery chemicals project and insurance claim receipt.
Read the summary - Medium impact
Neogen Chemicals receives ₹15 Crore interim payment for fire incident, total ₹155 Crore received
Neogen Chemicals received an additional ₹15 Crore on-account payment for a fire incident, bringing the total received to ₹155 Crore. The company recognized a net loss of ₹13.56 Crore for FY25. Replacement plant commissioning is slated for H1FY27, with interim production shifted to other sites.
Read the summary - Medium impact
Neogen Chemicals receives ₹15 Crore insurance payout, total ₹155 Crore received.
Neogen Chemicals received an additional ₹15 Crore as an on-account insurance payment for a fire incident, bringing the total received to ₹155 Crore. The company recognized losses of ₹348.16 Crore and an insurance claim receivable of ₹334.60 Crore. Replacement plant commissioning is slated for H1FY27.
Read the summary - Low impact
Neogen Chemicals Promoter Discloses Pledge of 13.19 Lakh Shares
Haridas Thakarshi Kanani, a promoter of Neogen Chemicals, declared that during FY26, 13,19,083 equity shares held by Dr. Harin Kanani were pledged on March 30, 2026. No other encumbrances were created, invoked, or released by the promoter group.
Read the summary - Low impact
Neogen Chemicals to Participate in PhillipCapital Investor Meet on June 23, 2026
Neogen Chemicals Limited will attend the India Inc. Unplugged event by PhillipCapital on June 23, 2026, in Mumbai. Management will discuss business, financial performance, and outlook. No UPSI will be shared.
Read the summary - High impact
Neogen Chemicals Q4 FY26 Earnings Call Transcript Released
Neogen Chemicals released its Q4 FY26 earnings call transcript. The company reported Q4 FY26 revenue of ₹247 crore (up 22% YoY) and PAT of ₹11 crore. FY26 revenue was ₹862 crore. Promoter group infused ₹161 crore for battery materials expansion. Dahej facility commissioning is expected by June 2026, Pakhajan by H1 FY27.
Read the summary - Low impact
Neogen Chemicals Announces Outcome of Earnings Conference Call on May 18, 2026
Neogen Chemicals Limited held an earnings conference call for analysts and investors on May 18, 2026, at 4:30 p.m. The audio recording of the call is available on the company's website.
Read the summary - High impact
Neogen Q4 FY26 Revenue Up 22% to ₹247 Cr; Board Recommends ₹1 Dividend
Neogen Chemicals reported Q4 FY26 consolidated revenue of ₹247 crore, up 22% YoY, with EBITDA at ₹44 crore (up 21%) and PAT at ₹11 crore. For FY26, revenue was ₹862 crore. The Board recommended a ₹1 dividend per share for FY26. Promoters infused ₹161 crore via preferential allotment for expansion. Pakhajan Greenfield Project commissioning for Electrolytes is expected in H1 FY27 and Salts in H2 FY27.
Read the summary - High impact
Neogen Chemicals Q4 FY26: Revenue Up 22% to ₹246.6 Cr, PAT Jumps 373% to ₹11.4 Cr
Neogen Chemicals reported Q4 FY26 consolidated revenue up 22% to ₹246.6 crore and PAT up 373% to ₹11.4 crore. Full year FY26 consolidated revenue rose 11% to ₹862 crore. Promoters infused ₹161 crore via preferential allotment. Dahej reconstruction to complete by June 2026. FY27 revenue guidance is ₹875-950 crore.
Read the summary - Medium impact
Neogen Chemicals Approves FY26 Audited Results, Recommends Dividend
Neogen Chemicals approved audited FY26 results, reporting a profit after tax of Rs. 46.96 Crore for the year and Rs. 14.66 Crore for the quarter ending March 31, 2026. The board recommended a final dividend of Re. 1 per share. Project costs for Neogen Ionics' Dahej and Pakhajan projects were revised to Rs. 428 Crore and Rs. 1,367 Crore respectively.
Read the summary - Medium impact
Neogen Chemicals Recommends Final Dividend of ₹1/Share for FY26; Reports Q4 Results
Neogen Chemicals recommended a final dividend of ₹1 per share for FY26, subject to shareholder approval. The company announced its audited financial results for Q4 FY26 and the full year. Revised project timelines and costs were also provided for its subsidiary, Neogen Ionics Limited.
Read the summary - Medium impact
Neogen Chemicals Approves Audited Results, Recommends Dividend of ₹1/Share
Neogen Chemicals approved its audited standalone and consolidated financial results for FY26. The Board recommended a final dividend of ₹1 per share. Project timelines and costs for its subsidiary, Neogen Ionics Limited, were revised, with Dahej Phase 1 at ₹428 crore (Feb 2027) and Pakhajan Phase 2 at ₹1,367 crore (Mar 2027).
Read the summary - Low impact
Neogen Chemicals Schedules Q4 FY26 Earnings Conference Call for May 18
Neogen Chemicals Limited will host an Earnings Conference Call on May 18, 2026, at 4:30 p.m. IST to discuss its Q4 FY26 results. The call will feature management discussions and a Q&A session for analysts and investors.
Read the summary - Medium impact
Neogen Chemicals Subsidiary Neogen Ionics to Invest ₹100.11 Crore in Neogen Morita New Material
Neogen Chemicals' subsidiary, Neogen Ionics, will invest ₹100.11 crore in step-down subsidiary Neogen Morita New Material via rights issue. This funds NML's CAPEX/OPEX and growth in Lithium-Ion Battery materials. NML's authorized capital increases to ₹99 crore. Transaction expected within 60 days.
Read the summary - Low impact
Neogen Chemicals Announces "Saksham Niveshak" Campaign for Unclaimed Dividends
Neogen Chemicals launches "Saksham Niveshak" campaign from April 1 to July 9, 2026. The initiative, in collaboration with IEPFA, urges shareholders to update KYC and bank details to claim unpaid dividends before they are transferred to IEPF. Procedures for physical and demat shares are detailed.
Read the summary - Low impact
Neogen Chemicals Initiates "Saksham Niveshak" Campaign for Unclaimed Dividends
Neogen Chemicals launches "Saksham Niveshak" campaign (April 1 - July 9, 2026) to help shareholders update KYC and claim unpaid dividends before transfer to IEPF. Shareholders can update details for FY 2018-19 to 2024-25.
Read the summary - Medium impact
Neogen Chemicals: Promoter Group Acquires 10 Lakh Shares Worth ₹161 Crore
Cadamba Solutions Private Limited, a promoter group member of Neogen Chemicals Limited, acquired 10,00,000 equity shares for ₹161 crore on April 18, 2026. This preferential allotment represents 3.79% of pre-allotment and 3.65% of post-allotment equity capital.
Read the summary - Medium impact
Cadamba Solutions Acquires 10 Lakh Neogen Shares for ₹161 Crore
Cadamba Solutions Private Limited, a promoter group entity, acquired 10,00,000 Neogen Chemicals shares for ₹161 crore on April 18, 2026. This preferential allotment represents 3.79% pre-allotment and 3.65% post-allotment equity. The acquisition was for cash consideration.
Read the summary - Medium impact
Cadamba Solutions Private Limited Acquires 3.79% Stake in Neogen Chemicals for ₹161 Crore
Cadamba Solutions Private Limited, a promoter group entity, acquired 10,00,000 Neogen Chemicals shares via preferential allotment on April 18, 2026. The deal value was ₹161 crore at ₹1,610 per share, representing 3.79% pre-allotment and 3.65% post-allotment equity.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio - Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio